Dr. Amaria on Genetically Modified TILs in Melanoma
1 Visningar
• 07/03/23
0
0
Bädda in
administrator
Prenumeranter
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna